Insights

Innovative Diagnostic Solutions Commonwealth Diagnostics International specializes in non-invasive at-home breath tests that assist healthcare providers in diagnosing gastrointestinal conditions such as SIBO, IMO, and various malabsorption issues, presenting opportunities to expand partnerships with clinics and hospitals seeking advanced diagnostic tools.

Strategic Collaborations The company's recent partnership with CliniOps and other healthcare entities indicates openness to collaborative efforts, which could be leveraged to introduce joint services, expand clinical trial participation, or bundle diagnostic solutions with other healthcare providers.

Tech-Driven Approach Utilizing modern technologies like PWA, Vue.js, and SEO optimization, CDI demonstrates a strong digital presence and data-driven approach, which can appeal to technology-focused healthcare organizations seeking innovative and scalable diagnostic solutions.

Growing Market Presence With revenue between one and ten million dollars and a niche focus on GI diagnostics, CDI is positioned as a specialized player in a growing segment, offering potential sales opportunities in expanding healthcare markets and specialty clinics looking for precise, at-home testing options.

Patient-Centric Focus The company's emphasis on safe, easy-to-use tests that improve patient outcomes aligns with current healthcare trends towards non-invasive, patient-friendly diagnostics, making these solutions attractive to clinics prioritizing high-quality, supportive care approaches.

Commonwealth Diagnostics International, Inc. Tech Stack

Commonwealth Diagnostics International, Inc. uses 8 technology products and services including RSS, Vue.js, jQuery, and more. Explore Commonwealth Diagnostics International, Inc.'s tech stack below.

RSS

Content Management System

Vue.js

Javascript Frameworks

jQuery

Javascript Libraries

PWA

Miscellaneous

PHP

Programming Languages

RankMath SEO

Web Platform Extensions

Nginx

Web Servers

Apache

Web Servers

Commonwealth Diagnostics International, Inc. Email Formats	Example	Percentage
FLast@commdx.com	JDoe@commdx.com	50%
FLast@commdx.com	JDoe@commdx.com	50%

Commonwealth Diagnostics International, Inc. Email Formats

Example

Percentage

FLast@commdx.com

JDoe@commdx.com

50%

FLast@commdx.com

JDoe@commdx.com

50%

Frequently Asked Questions

What is Commonwealth Diagnostics International, Inc.'s official website and social media links?

Commonwealth Diagnostics International, Inc.'s official website is commdx.com and has social profiles on LinkedIn.

What is Commonwealth Diagnostics International, Inc.'s NAICS code?

Commonwealth Diagnostics International, Inc.'s NAICS code is 62 - Health Care and Social Assistance.

How many employees does Commonwealth Diagnostics International, Inc. have currently?

As of January 2026, Commonwealth Diagnostics International, Inc. has approximately 21 employees across 1 continents, including North America. Key team members include Ceo: B. S.Chief Operating Officer & Chief Legal Officer: G. W. R.Chief Technology Officer: N. A.. Explore Commonwealth Diagnostics International, Inc.'s employee directory with LeadIQ.

What industry does Commonwealth Diagnostics International, Inc. belong to?

Commonwealth Diagnostics International, Inc. operates in the Hospitals and Health Care industry.

What technology does Commonwealth Diagnostics International, Inc. use?

Commonwealth Diagnostics International, Inc.'s tech stack includes RSSVue.jsjQueryPWAPHPRankMath SEONginxApache.

What is Commonwealth Diagnostics International, Inc.'s email format?

Commonwealth Diagnostics International, Inc.'s email format typically follows the pattern of FLast@commdx.com. Find more Commonwealth Diagnostics International, Inc. email formats with LeadIQ.

When was Commonwealth Diagnostics International, Inc. founded?

Commonwealth Diagnostics International, Inc. was founded in 2015.

Commonwealth Diagnostics International, Inc.

Hospitals and Health CareMassachusetts, United States11-50 Employees

Founded in 2015 in Salem, Mass., and operating out of its CLIA-certified laboratory and as an FDA-registered, ISO 13485-certified medical device manufacturer, Commonwealth Diagnostics International (CDI) helps providers identify and diagnose common sources of digestive distress and functional gastrointestinal ailments. 

CDI’s expansive portfolio of non-invasive at-home hydrogen and methane breath tests supports the diagnosis and treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO), as well as fructose malabsorption, lactose malabsorption, and sucrose malabsorption.

Focused on patient-centric principles, CDI breath tests are easy-to-use, quick, and safe for patients and support meaningful GI health outcomes by helping steer each practitioner’s approach to dietary modification, homeopathic remedies, nutritional supplementation, immune support, high-quality probiotics, and additional testing.

Insights

Similar companies to Commonwealth Diagnostics International, Inc.

Quest Diagnostics

Access Medical Laboratories

Genova Diagnostics

LetsGetChecked

Labcorp